Considering its compelling valuation metrics and high earnings growth prospects, GBX's stock is extremely undervalued; its EV/EBITDA ratio is extremely low at 2.99. Greenbrier is generating strong free cash flows and returns value to its …
As a percentage of GBX's recent stock price of $44.70, this dividend works out to approximately 0.56%, so look for shares of Greenbrier Companies Inc to trade 0.56% lower - all else being equal - when GBX shares open for trading on 4/24/18. …
It has underperformed by 24.20% the S&P500. In analysts note made public on 24 April, Rotork PLC (LON:ROR) stock
Hikma Pharmaceuticals Plc are listed in the Health Care sector within UK Main Market. Barclays Capital have set their target price at 850 GBX on its stock. This now indicates the analyst believes there is a potential downside of -24.3% …
The token sale for the Gibraltar Stock Exchange subsidiary closes six days ahead of schedule The Gibraltar
The balance of that day’s offering – on GBX – was taken up within nine seconds, Nick Cowan CEO of the Gibraltar Stock Exchange Group, confirmed yesterday. GBX had allowed a 14-day window for the RockToken issue. Of the almost …
Greenbrier Companies Inc. (NYSE: GBX) reported poor second fiscal quarter results on ... The consensus price target on the stock from nine analysts is near $49 which implies a potential upside of 6.5%. The company’s forward P/E ratio is …
AstraZeneca are listed in the Health Care sector within UK Main Market. Morgan Stanley have set a target price of 5250 GBX on its stock. This indicates the analyst now believes there is a potential upside of 8.3% from todays opening price …
In an analyst note revealed to investors and clients on Thursday morning, Sky Plc (LON:SKY) stock “Buy” was …
Brookfield Asset Management (NYSE: BAM) Cut estimates at Credit Suisse. The Greenbrier Companies (NYSE: GBX) …